Skip to main content
. Author manuscript; available in PMC: 2012 Jul 13.
Published in final edited form as: Clin Cancer Res. 2009 Dec 15;15(24):7693–7700. doi: 10.1158/1078-0432.CCR-09-1450

Table 2.

Genes for which increased expression was associated with increased recurrence risk

HUGO Gene Symbol Rank Gene Name EntrezGene ID Chromosome Nominal P Value Kon’rs Adjusted P Value Hazard Ratio Correlation with TOP2A
TOP2A 1 Topoisomerase II alpha 7153 17q21-q22 5.67E-06 0.01 1.55
DEPDC1 2 DEP domain containing 1 55635 1p31.2 8.39E-06 0.01 1.67 0.7
NUSAP1 3 nucleolar and spindle associated protein 1 51203 15q15.1 9.58E-06 0.01 1.64 0.56
AURKB 4 aurora kinase B 9212 17p13.1 1.21E-05 0.01 1.59 0.74
KIFC1 5 kinesin family member C1 3833 6p21.3 6.75E-05 0.0299 1.59 0.71
GAPDH 6 Glyceraldehyde 3 phosphate dehydrogenase 2597 12p13 8.07E-05 0.0339 2.55 <0.5
BUB1B 7 BUB1 budding uninhibited by benzimidazoles 1 homolog beta 701 15q15.1 0.00025 0.0399 6.69 0.65
BIRC5 8 baculoviral IAP repeat-containing 5 (survivin) 332 17q25 0.0003 0.0339 1.4 0.8
TYMS 9 Thymidylate synthase 7298 18p11.32 0.00041 0.0439 1.59 0.71
PLK1 10 polo-like kinase 1 5347 16p12.1 0.00042 0.0439 1.45 0.74